Wei‐Sing Chu

916 citations
15 papers · 667 indexed · h-index 13
Topics
Molecular Biology Techniques and Applications (3 papers)Acute Myeloid Leukemia Research (2 papers)Neuroendocrine Tumor Research Advances (2 papers)

In The Last Decade

Wei‐Sing Chu

15 papers receiving 645 citations

Peers

Wei‐Sing Chu
Comparison fields: 5 of 69
  • Molecular Biology 304
  • Oncology 189
  • Epidemiology 137
  • Surgery 122
  • Rheumatology 112
Replace Adam Mor with:
Adam Mor United States
Yukio Tsuura Japan
Kazuo Ōno Japan
Diana O. Treaba United States
L. A. Aarden Netherlands
Kristján Steinsson Iceland
Lucien E. Nochomovitz United States
G. J. Ossenkoppele Netherlands
Fabien Le Bras France
L Rönnblom Sweden
Wei‐Sing Chu relative to Adam Mor United States Adam Mor's profile →
Citations per field
00.5×1.5×
Adam Mor · 1×
Citations per year

Countries citing papers authored by Wei‐Sing Chu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Sing Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Sing Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Sing Chu more than expected).

Fields of papers citing papers by Wei‐Sing Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Sing Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Sing Chu. The network helps show where Wei‐Sing Chu may publish in the future.

Co-authorship network of co-authors of Wei‐Sing Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Sing Chu. A scholar is included among the top collaborators of Wei‐Sing Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Sing Chu. Wei‐Sing Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 55
2 20
3 43
4 112
5 61
6 31
7 46
8 5
9 93
10 40
11 38
12 13
13 1
14 13
15 96

About Wei‐Sing Chu

Wei‐Sing Chu is a scholar working on Gastroenterology, Immunology and Allergy and Hematology, having authored 15 papers that have together received 667 indexed citations. Recurring topics across this work include Molecular Biology Techniques and Applications (3 papers), Acute Myeloid Leukemia Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Hematology (96 citations), Rheumatology (112 citations) and Gastroenterology (40 citations). Wei‐Sing Chu has collaborated with scholars based in United States, United Kingdom and Pakistan. Frequent co-authors include Susan L. Abbondanzo, Nadine S. Aguilera, Jayashree Krishnan, Glauco Frizzera, Kondi Wong, P S Hasleton, Sylvie Lantuéjoul, E. Brambilla, Mary Beth Beasley and William D. Travis. Their work appears in journals such as Journal of Histochemistry & Cytochemistry, Human Pathology and American Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026